AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7917743 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane anaesthesia (mean dose 8.5 MAC-h)
Number of subjects: 21
Study 3253122 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 55
Study 3253122 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 55
Study 3253122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of anaesthesia
Number of subjects: 55
Study 31707767 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Nutritional Risk Index (GNRI) > 98 (no risk)
Number of subjects: 352
Study 31707767 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Nutritional Risk Index (GNRI) 92-98 (low risk)
Number of subjects: 352
Study 31707767 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Nutritional Risk Index (GNRI) < 92 (moderate/major risk)
Number of subjects: 352
Study 29643029 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS (fructo-oligosaccharides) for 5 days
Number of subjects: 35
Study 29643029 — intervention group
Group type: EXPERIMENTAL
Intervention: GOS (galacto-oligosaccharides) for 9 days
Number of subjects: 35
Study 29643029 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model based on initial gut microbiota data
Number of subjects: 35
Study 28109731 — intervention group
Group type: EXPERIMENTAL
Intervention: Food condition (participants who had recently eaten)
Number of subjects: 173
Study 28109731 — intervention group
Group type: COMPARATOR
Intervention: No food condition (participants who had not recently eaten)
Number of subjects: 173
Study 25142278 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 week gym and home walking exercise programme (n=13)
Number of subjects: 30
Study 25142278 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparator group
Number of subjects: 30
Study 23283590 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted MRI (ADC values before radiochemotherapy)
Number of subjects: 59
Study 23283590 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted MRI (ΔADC)
Number of subjects: 59
Study 21622083 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved biomass stove (Patsari stove)
Number of subjects: 63
Study 17443125 — intervention group
Group type: COMPARATOR
Intervention: 0 mg nicotine via nasal spray
Number of subjects: 28
Study 17443125 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg nicotine via nasal spray
Number of subjects: 28
Study 17443125 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine via nasal spray
Number of subjects: 28
Study 17443125 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (any dose)
Number of subjects: 28
Study 17274039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline (CAB) 2 or 3 mg daily for 30 weeks
Number of subjects: 361
Study 17274039 — intervention group
Group type: COMPARATOR
Intervention: Levodopa 200 or 300 mg daily for 30 weeks
Number of subjects: 361
Study 17274039 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 361
Study 17274039 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 361
Study 15492340 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse care management (structured telephone surveillance and treatment for heart failure, coordination with primary care physicians)
Number of subjects: 462
Study 15492340 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 462
Study 11525777 — intervention group
Group type: EXPERIMENTAL
Intervention: etodolac (200 or 400 b.i.d.)
Number of subjects: 5
Study 11525777 — intervention group
Group type: EXPERIMENTAL
Intervention: meloxicam (7.5 or 15 q.d.)
Number of subjects: 5
Study 11525777 — intervention group
Group type: EXPERIMENTAL
Intervention: nimesulide (100 or 200 b.i.d.)
Number of subjects: 5
Study 11525777 — intervention group
Group type: EXPERIMENTAL
Intervention: nabumetone (500 or 1000 b.i.d.)
Number of subjects: 5
Study 11525777 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen (500 b.i.d.)
Number of subjects: 5
Study 9632874 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP (group 1 = 52 cases)
Number of subjects: 108
Study 9632874 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP (group 1)
Number of subjects: 108
Study 9632874 — intervention group
Group type: COMPARATOR
Intervention: Open (group 2 = 56 cases)
Number of subjects: 108
Study 9632874 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP
Number of subjects: 108
Study 9632874 — intervention group
Group type: COMPARATOR
Intervention: Open
Number of subjects: 108
Study 8160609 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet and daily physical exercise
Number of subjects: 104
Study 8160609 — intervention group
Group type: COMPARATOR
Intervention: Usual care by private physician
Number of subjects: 104
Study 3042053 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF + tamoxifen (30 mg per day during 2 years)
Number of subjects: 326
Study 3042053 — intervention group
Group type: COMPARATOR
Intervention: CMF (chemotherapy alone)
Number of subjects: 326
Study 31490429 — intervention group
Group type: EXPERIMENTAL
Intervention: S + SA
Number of subjects: 27
Study 31490429 — intervention group
Group type: EXPERIMENTAL
Intervention: E + SA
Number of subjects: 27
Study 31490429 — intervention group
Group type: EXPERIMENTAL
Intervention: C + SA
Number of subjects: 27
Study 31490429 — intervention group
Group type: COMPARATOR
Intervention: SA
Number of subjects: 27
Study 31501112 — intervention group
Group type: COMPARATOR
Intervention: Standard GIST (n=30) delivered via outpatient sessions for 2.5 hours once per week for 12 weeks, plus one initial orientation session.
Number of subjects: 60
Study 31501112 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive GIST (n=30) participants admitted to an inpatient rehabilitation unit for 4 weeks (two times 3 days/week, two times 4 days/week) with full-day sessions each week.
Number of subjects: 60
Study 31501112 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (WL) for participants receiving intensive GIST after WL.
Number of subjects: 60
Study 27761942 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced carbohydrate counting using an automated bolus calculator (ABC group)
Number of subjects: 168
Study 27761942 — intervention group
Group type: COMPARATOR
Intervention: Advanced carbohydrate counting using mental calculations (MC group)
Number of subjects: 168
Study 24408892 — intervention group
Group type: EXPERIMENTAL
Intervention: PEERS(®) treatment group (TG)
Number of subjects: 47
Study 22018935 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diet, physical activity, and meditation intervention
Number of subjects: 47
Study 22018935 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 47
Study 22018935 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fruit and fiber intakes
Number of subjects: 47
Study 22018935 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased saturated fatty acid intake
Number of subjects: 47
Study 22018935 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased or maintained saturated fatty acid intake
Number of subjects: 47
Study 21938126 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream
Number of subjects: 100
Study 17403126 — intervention group
Group type: COMPARATOR
Intervention: Metformin and twice daily biphasic 30/70 human insulin mixture (n = 27)
Number of subjects: 82
Study 17403126 — intervention group
Group type: COMPARATOR
Intervention: Metformin and bedtime NPH insulin (n = 26)
Number of subjects: 82
Study 17403126 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin, bedtime NPH insulin and mealtime repaglinide (n = 25)
Number of subjects: 82
Study 17403126 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 82
Study 15871642 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg intravenously (n=37)
Number of subjects: 78
Study 15871642 — intervention group
Group type: COMPARATOR
Intervention: prochlorperazine 10 mg intramuscularly (n=41)
Number of subjects: 78
Study 12851985 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF-alpha immunobiologics (e.g. etanercept, infliximab)
Number of subjects: 0
Study 12851985 — intervention group
Group type: EXPERIMENTAL
Intervention: Apoptosis-inducing treatments
Number of subjects: 0
Study 9834301 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cytarabine
Number of subjects: 0
Study 9834301 — intervention group
Group type: COMPARATOR
Intervention: Autologous marrow transplantation
Number of subjects: 0
Study 9834301 — intervention group
Group type: COMPARATOR
Intervention: Allogeneic marrow transplantation
Number of subjects: 0
Study 8012440 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminaria digitata tents
Number of subjects: 30
Study 8012440 — intervention group
Group type: COMPARATOR
Intervention: Cervical dilatation without Laminaria tents
Number of subjects: 30
Study 2607127 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofepramine (140 mg)
Number of subjects: 4
Study 2607127 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 30676482 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) for 3 months
Number of subjects: 194
Study 30676482 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 194
Study 28838362 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC-based educational intervention
Number of subjects: 196
Study 28838362 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 196
Study 26272720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 10 mg iv at the time of CSE
Number of subjects: 596
Study 26272720 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 596
Study 24030086 — intervention group
Group type: EXPERIMENTAL
Intervention: Torsional phacoemulsification
Number of subjects: 52
Study 24030086 — intervention group
Group type: COMPARATOR
Intervention: Longitudinal phacoemulsification
Number of subjects: 52
Study 24030086 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative CCT
Number of subjects: 52
Study 21170794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion (10 min, 10°C)
Number of subjects: 20
Study 21170794 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral water immersion (10 min, 35°C)
Number of subjects: 20
Study 18415103 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ IOL (22.4+/‐2.0 D)
Number of subjects: 106
Study 18415103 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof IQ IOL
Number of subjects: 106
Study 18415103 — intervention group
Group type: COMPARATOR
Intervention: AcrySof SA60AT
Number of subjects: 106
Study 18415103 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal asphericity (Q value)
Number of subjects: 106
Study 17012454 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (80 units injected into pelvic floor muscles)
Number of subjects: 60
Study 17012454 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline injection)
Number of subjects: 60
Study 14612479 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medications and/or 6 to 8 sessions of psychotherapy (Problem‐Solving Treatment in Primary Care)
Number of subjects: 1801
Study 11177604 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of isolated disseminated tumor cells in bone marrow (IDTBM) using monoclonal antibody A 45‐B/B3
Number of subjects: 293
Study 8959119 — intervention group
Group type: EXPERIMENTAL
Intervention: EDC spirometer
Number of subjects: 10
Study 8959119 — intervention group
Group type: COMPARATOR
Intervention: mini-Wright peak flow meter
Number of subjects: 10
Study 1431257 — intervention group
Group type: COMPARATOR
Intervention: M15 (15 mg/kg)
Number of subjects: 199
Study 1431257 — intervention group
Group type: EXPERIMENTAL
Intervention: M25 (25 mg/kg)
Number of subjects: 199
Study 3881630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral immunotherapy with Corynebacterium parvum followed 2 weeks later by surgery and postoperative C parvum for 2 years
Number of subjects: 176
Study 3881630 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 176
Study 3881630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral C parvum
Number of subjects: 176
Study 29908472 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM Attention Dot‐Probe Training (DPT)
Number of subjects: 139
Study 29908472 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM Approach‐Avoidance Training (AAT)
Number of subjects: 139
Study 29908472 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 139
Study 27504918 — intervention group
Group type: EXPERIMENTAL
Intervention: Pessary treatment
Number of subjects: 162
Study 27504918 — intervention group
Group type: COMPARATOR
Intervention: PFMT
Number of subjects: 162
Study 25123333 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-detected lung cancers from positive CXR screens
Number of subjects: 77445
Study 25123333 — intervention group
Group type: EXPERIMENTAL
Intervention: True interval lung cancers
Number of subjects: 77445
Study 22816878 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol maintenance and reliever therapy (Symbicort SMART™, Turbuhaler®) 160/4.5 μg twice daily plus as needed
Number of subjects: 0
Study 22816878 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixed-dose treatment (ICS/LABA plus SABA or formoterol)
Number of subjects: 0
Study 20423357 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological support group with respiratory-sinus-arrhythmia biofeedback training (n = 106)
Number of subjects: 212
Study 20423357 — intervention group
Group type: COMPARATOR
Intervention: Control group with standard care (n = 106)
Number of subjects: 212
Study 18662913 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% ciclosporin and dexamethasone 0.1%
Number of subjects: 47
Study 18662913 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone only
Number of subjects: 47
Study 15957600 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage algorithm for mammogram registration
Number of subjects: 0
Study 14534844 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC dressings
Number of subjects: 6
Study 14534844 — intervention group
Group type: COMPARATOR
Intervention: Moist gauze dressings
Number of subjects: 6
Study 10836651 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab (1 mg/kg for five doses given every 2 weeks)
Number of subjects: 36
Study 10836651 — intervention group
Group type: COMPARATOR
Intervention: Control group (mycophenolate mofetil, prednisone, and a calcineurin inhibitor)
Number of subjects: 36
Study 8857000 — intervention group
Group type: EXPERIMENTAL
Intervention: Information search about each alternative
Number of subjects: 0
Study 8857000 — intervention group
Group type: COMPARATOR
Intervention: Directly available information to another group
Number of subjects: 0
Study 8857000 — intervention group
Group type: EXPERIMENTAL
Intervention: Information search and sequence of responding for three errands
Number of subjects: 0
Study 1281903 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding metal stent
Number of subjects: 105
Study 1281903 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene stent
Number of subjects: 105
Study 1281903 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 105
Study 1281903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness
Number of subjects: 105
Study 6392050 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg molsidomine sustained-release
Number of subjects: 11
Study 6392050 — intervention group
Group type: COMPARATOR
Intervention: 2 mg molsidomine
Number of subjects: 11
Study 31304887 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention group
Number of subjects: 0
Study 31304887 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard relapse prevention group
Number of subjects: 0
Study 31304887 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual group
Number of subjects: 0
Study 31304887 — intervention group
Group type: COMPARATOR
Intervention: Control group (marijuana or opiates users)
Number of subjects: 0
Study 29456191 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg azithromycin (low-dose)
Number of subjects: 583
Study 29456191 — intervention group
Group type: COMPARATOR
Intervention: 30 mg/kg azithromycin (standard-dose)
Number of subjects: 583
Study 29456191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (20 mg/kg and 30 mg/kg azithromycin)
Number of subjects: 583
Study 26970111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (8-week program with mindful spin-bike training)
Number of subjects: 47
Study 26970111 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 47
Study 24597610 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft orange contact lenses (SOCL)
Number of subjects: 15
Study 24597610 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic exposure to reduced short wavelength light (SOCL for two weeks)
Number of subjects: 15
Study 24597610 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic reduced blue light exposure
Number of subjects: 15
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage (energy-matched fruits and vegetables)
Number of subjects: 34
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid (energy-matched fruits and vegetables)
Number of subjects: 34
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid fruits and vegetables (lean group)
Number of subjects: 34
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid fruits and vegetables (overweight/obese group)
Number of subjects: 34
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage (lean group)
Number of subjects: 34
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage (overweight/obese group)
Number of subjects: 34
Study 21720441 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage (obese group)
Number of subjects: 34
Study 20140434 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tube in place (n = 29)
Number of subjects: 60
Study 20140434 — intervention group
Group type: COMPARATOR
Intervention: No nasogastric tube (n = 31)
Number of subjects: 60
Study 17883845 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured programme for treating depression
Number of subjects: 400
Study 17883845 — intervention group
Group type: COMPARATOR
Intervention: Usual management
Number of subjects: 400
Study 16383068 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/100 ml alcohol
Number of subjects: 16
Study 16383068 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/100 ml alcohol
Number of subjects: 16
Study 16383068 — intervention group
Group type: COMPARATOR
Intervention: Alcohol placebo
Number of subjects: 16
Study 12230153 — intervention group
Group type: EXPERIMENTAL
Intervention: Friends (5-year-olds)
Number of subjects: 217
Study 12230153 — intervention group
Group type: COMPARATOR
Intervention: Nonfriends (5-year-olds)
Number of subjects: 217
Study 12230153 — intervention group
Group type: EXPERIMENTAL
Intervention: Friends (4-year-olds)
Number of subjects: 217
Study 12230153 — intervention group
Group type: COMPARATOR
Intervention: Nonfriends (4-year-olds)
Number of subjects: 217
Study 10936121 — intervention group
Group type: EXPERIMENTAL
Intervention: Red signal observed by color flow imaging
Number of subjects: 191
Study 10936121 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodynamic studies in patients with RF signal
Number of subjects: 191
Study 8737213 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-rich meal (600 ml, approximately 4000 kJ)
Number of subjects: 14
Study 8737213 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich meal (600 ml, approximately 4000 kJ)
Number of subjects: 14
Study 8737213 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced meal (600 ml, approximately 4000 kJ)
Number of subjects: 14
Study 8737213 — intervention group
Group type: COMPARATOR
Intervention: Water (600 ml)
Number of subjects: 14
Study 1412115 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance breathing training using a resistive breathing device (PFLEX) for 10 minutes five times daily with progressively larger resistances.
Number of subjects: 82
Study 1412115 — intervention group
Group type: COMPARATOR
Intervention: Sham device providing minimal resistance.
Number of subjects: 82
Study 3895960 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose treatment with 500 mg clotrimazole
Number of subjects: 199
Study 3895960 — intervention group
Group type: COMPARATOR
Intervention: 6-day treatment with 100 mg clotrimazole
Number of subjects: 199
Study 31882650 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally disordered crystal
Number of subjects: 2
Study 31882650 — intervention group
Group type: COMPARATOR
Intervention: Ordered crystal
Number of subjects: 2
Study 30037277 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular Endothelial Growth Factor (VEGF)
Number of subjects: 100
Study 26372481 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine 25 mg
Number of subjects: 18
Study 26372481 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine 200 mg
Number of subjects: 18
Study 26372481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24629048 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-viewing with parents
Number of subjects: 99
Study 24629048 — intervention group
Group type: COMPARATOR
Intervention: Co-viewing with friends
Number of subjects: 99
Study 22732313 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3-ppm ozone for 2 hours while intermittently exercising
Number of subjects: 23
Study 22732313 — intervention group
Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 23
Study 20152065 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual CBT treatment
Number of subjects: 102
Study 20152065 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT treatment
Number of subjects: 102
Study 20152065 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 102
Study 18049345 — intervention group
Group type: EXPERIMENTAL
Intervention: QI-Therapy
Number of subjects: 1188
Study 18049345 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1188